- Query in any language with multilingual search
- Access EUR-Lex and EU Commission case law
- See relevant paragraphs highlighted instantly
Similar Documents
Explore similar documents to your case.We Found Similar Cases for You
Case T-573/10: Order of the General Court of 8 March 2012 — Octapharma Pharmazeutika v EMA (Medicinal products for human use — Changes to a plasma master file (PMF) — Fees payable to the EMA — Act with adverse effects — Measure merely confirmatory — Manifest inadmissibility)
ECLI:EU:UNKNOWN:62010TB0573
62010TB0573
With us you find everything. Try it now!
I imagine what I want to write in my case, I write it in the search engine and I get exactly what I wanted. Thank you!
Valentina R., lawyer
28.4.2012
Official Journal of the European Union
C 126/17
(Case T-573/10) (<span class="super">1</span>)
(Medicinal products for human use - Changes to a plasma master file (PMF) - Fees payable to the EMA - Act with adverse effects - Measure merely confirmatory - Manifest inadmissibility)
2012/C 126/34
Language of the case: German
Parties
Applicant: Octapharma Pharmazeutika Produktionsgesellschaft mbH (Vienna, Austria) (represented by: I. Brinker and T. Holzmüller, lawyers, and J. Schwarze, Professor)
Defendant: European Medicines Agency (EMA) (represented by: V. Salvatore, acting as Agent, and H.-G. Kamann and P. Gey, lawyers)
Re:
Application for annulment of the letter of 21 October 2010 (EMA/643425/2010) by which the European Medicines Agency (EMA) refused to repay to the applicant the sum of EUR 180 700 corresponding to the difference between, on the one hand, the sum the applicant paid to it in respect of fees for the examination of variations to the terms of a marketing authorisation for medicinal products for human use and veterinary medicinal products and, on the other hand, the sum which the applicant maintains it should have paid.
Operative part of the order
1.The action is dismissed.
2.Octapharma Pharmazeutika Produktionsgesellschaft mbH shall pay the costs.
(<span class="super">1</span>) OJ C 55, 19.2.2011.